Within PAH-PASMCs, Gamitrinib reduced the endogenous overexpression of mtDNA maintenance genes, DNA polymerase γ (POLG1) and OGG1 (Figure 4) [88]. This evidence concerns the gene OGG1 and pulmonary arterial hypertension.